Radiologists’ Perspectives on AI Integration in Mammographic Breast Cancer Screening: A Mixed Methods Study
Cancers · 30.10.2025 · 17 (21) · 3491
DOI: 10.3390/cancers17213491 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Cancers, online erschienen am 30.10.2025. Verfasst von Serene Si Ning Goh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, National University Hospital Singapore, Singapore 119077, Singapore. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University Health System.
Abstract (Originalsprache)
Background/Objectives: Artificial intelligence (AI) is increasingly applied in breast imaging, with potential to improve diagnostic accuracy and reduce workload in mammographic breast cancer screening. However, real-world integration of AI into national screening programs remains limited, and little is known about radiologists’ perspectives in Asian settings. This study aimed to explore radiologists’ perceptions of AI adoption in Singapore’s breast screening program, focusing on perceived benefits, barriers, and requirements for safe integration.
Methods
We conducted a mixed methods study involving a cross-sectional survey of 17 radiologists with prior experience using AI-assisted mammography, followed by semi-structured interviews with 10 radiologists across all three public healthcare clusters. The survey measured confidence in AI, attitudes toward its diagnostic role, and integration preferences. Interviews were analyzed thematically, guided by the Unified Theory of Acceptance and Use of Technology (UTAUT) framework.
Results
Among survey respondents, 64.7% recommended AI as a companion reader, though only 29.4% rated its performance as comparable to humans. Confidence was highest when AI was validated on local datasets (mean 9.3/10). Interviews highlighted AI’s strengths in routine, fatigue-prone tasks, but skepticism for complex cases. Concerns included false positives, workflow inefficiencies, medico-legal accountability, and long-term costs. Radiologists emphasized the importance of national guidelines, local validation, and clear role definition to build trust.
Conclusions
Radiologists support AI as an adjunct to, but not a replacement for, human readers in breast cancer screening. Adoption will require robust regulatory frameworks, seamless workflow integration, transparent validation on local data, and structured user training to ensure safe and effective implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, National University Hospital Singapore, Singapore 119077, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, Singapore 117549, Singapore.
- NUS Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr, Singapore 117597, Singapore.
- Department of Diagnostic Imaging, National University Hospital Singapore, Singapore 119074, Singapore.
ORCID-Profile: Serene Si Ning Goh, Qin Xiang Ng, Felicia Jia Hui Chan, Pooja Jagmohan, Shahmir H Ali, Gerald Choon Huat Koh
Förderung
- National University Health System
Zitieren
APA
Goh, S. S. N., Ng, Q. X., Chan, F. J. H., Goh, R. S. J., Jagmohan, P., Ali, S. H., & Koh, G. C. H. (2025). Radiologists’ Perspectives on AI Integration in Mammographic Breast Cancer Screening: A Mixed Methods Study. Cancers, 17(21), 3491. https://doi.org/10.3390/cancers17213491
Vancouver
Goh SSN, Ng QX, Chan FJH, Goh RSJ, Jagmohan P, Ali SH, et al. Radiologists’ Perspectives on AI Integration in Mammographic Breast Cancer Screening: A Mixed Methods Study. Cancers. 2025;17(21):3491. doi:10.3390/cancers17213491
BibTeX
@article{Goh2025,
author = {Goh, Serene Si Ning and Ng, Qin Xiang and Chan, Felicia Jia Hui and Goh, Rachel Sze Jen and Jagmohan, Pooja and Ali, Shahmir H and Koh, Gerald Choon Huat},
title = {Radiologists’ Perspectives on AI Integration in Mammographic Breast Cancer Screening: A Mixed Methods Study},
journal = {Cancers},
year = {2025},
volume = {17},
number = {21},
pages = {3491},
doi = {10.3390/cancers17213491}
}
EUVIMED